Accession Number: | 0001239819-19-000121 |
Date: | 2019-09-04 |
Issuer: | LUNA INNOVATIONS INC (LUNA) |
Original Submission Date: |
CARILION CLINIC
C/O LUNA INNOVATIONS INCORPORATED
301 1ST STREET SW, SUITE 200
ROANOKE, VA 24011
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-04 | S | 71,701 | d | $6.32 | 964,330 | direct | ||
COMMON STOCK | 2019-09-05 | S | 48,953 | d | $6.71 | 915,377 | direct | ||
COMMON STOCK | 2019-09-06 | S | 51,047 | d | $6.70 | 864,330 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | price reflected is a weighted-average sale price for the shares sold. the range of sales prices for the transaction reported was $6.25 - $6.38 per share, inclusive. the reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. |
f2 | price reflected is a weighted-average sale price for the shares sold. the range of sales prices for the transaction reported was $6.60 - $6.86 per share, inclusive. the reporting person is undertaken to provide upon request of the staff, the issuer, or a secondary holder of the issuer, full information regarding the number of shares sold at each price. |